Hence, GPER may be considered as a further therapeutic target in cardiac diseases on the basis of its involvement in myocardial inotropism and lusitropism as well as in the expression of the apoptotic and fibrotic factors HIF-1α and CTGF, respectively. Here, CCN2 is linked to heart disorder.